Pharma Sustainability Days

Why pharma must transform now? Quantis brings a strategic perspective on turning decarbonization into a driver of resilience and financial performance.

Pharma Sustainability Days focuses on how the pharmaceutical sector can respond to rising cost volatility, increasing regulatory pressure and growing expectations on environmental performance. For many companies, emissions sit largely in the value chain, making decarbonization more complex and harder to control. At the same time, inaction is becoming a financial risk — affecting margins, access to markets and operational stability. The challenge is no longer whether to act, but how to prioritize and scale transformation in a way that delivers measurable returns.

Quantis will contribute a session exploring why transformation is now a strategic imperative for pharma. The discussion will unpack where emissions and risks sit across the value chain, how companies can move from fragmented efforts to structured transformation, and what it takes to unlock return on investment from decarbonization. Attendees will gain a clear view on how to manage cost and compliance pressures while turning climate action into a lever for performance and long-term competitiveness.

Our sessions

Why Pharma Must Transform Now? A strategic imperative

Wednesday 27 May, 1:00 – 1:15 pm

Pharmaceutical companies are entering a period of heightened pressure, where cost volatility, regulatory demands and value chain emissions are converging to challenge margins and operational stability. This session explores why transformation must happen now, and how to turn decarbonization into a lever for risk management and financial performance.

Speakers

Alice Joubay
Principal Strategist
Quantis Switzerland

Learn more

Transforming manufacturing processes for a low-impact pharmaceutical industry

Wednesday 27 May, 2:30 – 2:45 pm

Pharmaceutical companies are entering a period of heightened pressure, where cost To conclude this session on transforming manufacturing processes for a low-impact pharmaceutical industry, a panel discussion moderated by Alice Joubay will bring together all speakers for a more open and interactive exchange.

The discussion will focus on the broader transformation underway across pharmaceutical manufacturing, looking at how sustainability strategies are moving from intention to operational reality, and how innovation and collaboration are reshaping industrial models towards lower-impact solutions.

This will be an opportunity to step back from individual approaches and explore the key conditions needed to accelerate meaningful change across the value chain. The audience will be invited to engage directly with the speakers and moderator to enrich the conversation.

Learn more